UBS Group AG - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 35 filers reported holding HAEMONETICS CORP MASS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q2 2023$12,764
-11.5%
15,000
-11.8%
0.00%
Q1 2023$14,424
-99.0%
17,0000.0%0.00%
-100.0%
Q4 2022$1,404,710
+9933.6%
17,0000.0%0.00%
Q3 2022$14,000
+7.7%
17,000
+6.2%
0.00%
Q2 2022$13,000
+116.7%
16,000
+128.6%
0.00%
Q1 2022$6,0007,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 33,106,000$28,184,1312.08%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,362,6921.04%
Kohlberg Kravis Roberts & Co. L.P. 39,055,000$33,332,7791.00%
ADVENT CAPITAL MANAGEMENT /DE/ 60,053,000$51,254,2150.97%
DeepCurrents Investment Group LLC 20,750,000$17,615,0920.69%
SSI INVESTMENT MANAGEMENT LLC 10,967,000$9,305,3140.65%
Quaero Capital S.A. 900,000$768,4200.56%
Aequim Alternative Investments LP 20,500,000$17,496,4020.56%
STEELHEAD PARTNERS LLC 9,500,000$8,087,6350.53%
MACKAY SHIELDS LLC 19,791,000$16,891,2800.46%
View complete list of HAEMONETICS CORP MASS shareholders